FDA Adverse Event
Malfunction
Summary report: N
ULTEGRA RPFA-TRAP
MDR report key: 280682
·
Received June 2, 2000
Report
- Report Number
- 2031760-2000-00005
- Event Type
- Malfunction
- Date Received
- June 2, 2000
- Date of Event
- May 3, 2000
- Report Date
- June 2, 2000
- Manufacturer
- ACCUMETRICS
- Product Code
- JOZ
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NJ, US
- Reporter Occupation
- OTHER
Narratives
Description of Event or Problem · 1
A MANUFACTURER'S FIELD REPRESENTATIVE WAS DEMONSTRATING THE ULTEGRA RPFA-TRAP TO A DOCTOR USING A BLOOD SAMPLE OBTAINED FROM A PT WHO HAD NOT REC'D ANY "GP LLB/LLLA" INHIBITOR DRUG. A TEST RESULT OF 43 "PAU" WAS OBTAINED, WHICH IS LOWER THAN THE BASELINE (PRE-DRUG) REFERENCE RANGE CITED IN THE DEVICE PACKAGE INSERT (125-330 "PAU"). A SECOND BLOOD SAMPLE WAS DRAWN FROM THE PT, AND A TEST RESULT OF 259 "PAU" WAS OBTAINED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ULTEGRA RPFA-TRAP | PLATELET FUNCTION ASSAY | JOZ | ACCUMETRICS | NA | W03863 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 60 YR | PATIENT WAS TREATED WITH ASPIRIN, HEPARIN AND A| LIPID LOWERING DRUG. |